Harris Pharmaceutical's primary strategy is to develop, manufacture, and commercialize ANDAs and NDAs. At the same time, in order to offer our customers a varied and complete dermatological product portfolio, we will also be acquiring or licensing additional products that fulfill our niche.
Harris products are marketed through national wholesalers and distributors, and direct to major warehousing customers. Our customer markets include wholesaler multi-source programs, chain drug stores, managed healthcare providers, and institutional and government healthcare providers.
